Navigation Links
Alcohol Could Damage Youngsters' Brain

Alcohol could cause damage to the brain of youngsters, says a study, which stresses that teenagers should know what liquor misuse can do to them. //

Thomas Heffernan, a psychologist at Northumbria University, examined over 100 college students for the research presented at the British Psychological Society's annual conference in York, reported the online edition of Daily Mail.

Half the students were 'excessive drinkers', consuming an average of 27 units of alcohol a week - the equivalent of a bottle of spirits. The others drank rarely or not at all.

The subjects were asked how often they had forgotten things they planned or needed to do in the future, such as locking the door or posting a letter.

The heavy drinkers were much more forgetful, and found remembering to carry out immediate simple tasks particularly difficult.

A parallel study of youngsters who smoked around two packets of cigarettes a week tended to have problems remembering more distant future events, such as meeting a friend in a week's time.

While earlier studies have shown that smoking and drinking affect teenagers' ability to recall past events, this is the first time they have been shown to harm the ability to remember future tasks.

Heffernan said it was likely that both substances are damaging the brain at a crucial point in its development.

"Parents need to take much more responsibility. That includes providing their children with as much information as they can about what alcohol misuse can do to them," the researcher said.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Alcohol shrinks brain
2. Alcohol linked to brain activity
3. Alcohol within the body
4. Alcoholism Drug Fails To Prevent Drinking Relapses
5. Alcoholics are prone to disability
6. Alcohol decreases risk of dementia
7. Alcohol injures stress hormone response
8. Role of wives of Alcoholics
9. Antiseizure Drug in help for Alcoholics
10. Alcohol is no tonic for sleep
11. Alcohol and Sun Don’t Mi
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alcohol Could Damage Youngsters Brain

(Date:7/2/2009)...Leaders to Support Principles to Govern Health Ins...RNewswire-USNewswire/ -- Nearly nine out of ten vo... have too much influence over how doctors care for...support the concept of a "Health Insurer Code of C...nciples for health insurance companies with respec...
(Date:7/2/2009)...swire-USNewswire/ -- Pro-life forces won an import...uled to uphold a state law regulating that abortio...dministering RU-486 (also known as the "abortion p...g the drug. , , The ruling came in Rogers v. ...hood to a 2004 law requiring that those administer...
(Date:7/2/2009)...PRNewswire-USNewswire/ -- A new analysis of the in...n between the ages of 0 to 84 from 2000 to 2005 sh...sued by the Ministry of Health, with the sharpest ...p studied (ages 25 to 44). , , The new results,...k major breast surgeries rather than official esti...
(Date:7/2/2009)...own one set of neurons, another set wakes up: stud... -- New information about brain circuit activity m... aid Ambien (zolpidem) walk, eat, talk on the phon...out remembering it the next morning. , The drug... patients into a conscious state. , In experime...
Breaking Medicine News(10 mins):Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 2Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 4Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 5Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 6Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 3Health News:Odd Behaviors on Ambien Linked to Brain Circuitry 2
...d payout when the Los Angeles archdiocese agreed t...l abuse by priests . Divided by the 508 plaintiff...$1.3 million per person. But the actual payouts wi... victims receiving more than $3 million and some a...
...eith Urban insists that his 90 day stint at the Be...at saved his marriage to Nicole Kidman from collap... October 2006, shortly after the couple wed in Jun...wever, insists that entering rehab at the time was...
...is needed to address gender barriers to careers in...today Key findings from the year-long Women in Ac...A conference. A preliminary report states that: W...ikingly under-represented in the university sector...
...player Ben Czislowski was in for a shock when it w...ved with a rival's tooth dangerously embedded in h...m Manly in the Queensland Cup, had the tooth remov...e startling discovery. The tooth belongs to 22-yea...
Other Medicine News:Health News:Sexual Abuse Payout Re-opens Old Wounds 2Health News:Sexual Abuse Payout Re-opens Old Wounds 3Health News:Female Doctors Facing Barriers to Careers in Education and Research, Study Finds 2Health News:Lost And Found -Tooth In A Sportsman's Head 2
(Date:6/29/2009)...Biotherapeutics Based On Naturally Resected tRNA S... -- Pangu BioPharma, a subsidiary of aTyr Pharma i...rd patent application on proprietary, naturally oc...h tRNA synthetases are universal and essential com...l organisms, human synthetases have naturally occu...
(Date:6/28/2009)...tugal, June 29 Data presented,tod...t with the novel,once-daily anti-epileptic Zebin... a marked and sustained decrease in seizure freque...he one-year extension of a pivotal Eslicarbazepine...ternational Congress for Epilepsy in,Budapest, Hu...
(Date:6/26/2009)...Newswire-FirstCall/ -- Sanofi-aventis (EURONEXT:... data associated with a retrospective follow-up of...a clearly show that no definitive conclusions can ...between Lantus(R) (insulin glargine [rDNA] injecti... authors of the study point out. , , Clinical s...
(Date:6/26/2009)...proval of New Anti-TNF Therapy in Three Rheumatic ... , HORSHAM, Pa. and KENILWORTH, N.J., June 26 /PR... and Schering-Plough Corporation (NYSE: SGP ) an...ducts for Human Use (CHMP) of the European Medicin...ending the approval of SIMPONI(TM) (golimumab) as ...
Breaking Medicine Technology:Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10New Study 3A Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4484 1New Study 3A Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4484 2New Study 3A Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4484 3New Study 3A Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4484 4New Study 3A Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4484 5OncoGenex Pharmaceuticals Announces OGX 427 Treatment Demonstrates Safety Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Mar 12365 1OncoGenex Pharmaceuticals Announces OGX 427 Treatment Demonstrates Safety Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Mar 12365 2OncoGenex Pharmaceuticals Announces OGX 427 Treatment Demonstrates Safety Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Mar 12365 3OncoGenex Pharmaceuticals Announces OGX 427 Treatment Demonstrates Safety Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Mar 12365 4OncoGenex Pharmaceuticals Announces OGX 427 Treatment Demonstrates Safety Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Mar 12365 5Video 3A Phase III Study Data With Vandetanib 28Zactima 28TM 29 29 in Patients With Advanced Non Small Cell Lung Cancer 28NSCLC 29 Presented at Amer 4482 1Video 3A Phase III Study Data With Vandetanib 28Zactima 28TM 29 29 in Patients With Advanced Non Small Cell Lung Cancer 28NSCLC 29 Presented at Amer 4482 2Video 3A Phase III Study Data With Vandetanib 28Zactima 28TM 29 29 in Patients With Advanced Non Small Cell Lung Cancer 28NSCLC 29 Presented at Amer 4482 3Video 3A Phase III Study Data With Vandetanib 28Zactima 28TM 29 29 in Patients With Advanced Non Small Cell Lung Cancer 28NSCLC 29 Presented at Amer 4482 4Video 3A Phase III Study Data With Vandetanib 28Zactima 28TM 29 29 in Patients With Advanced Non Small Cell Lung Cancer 28NSCLC 29 Presented at Amer 4482 5Wyeth Donates 24100 000 to ASCO Cancer Foundation 28R 29 to Support Cancer Prevention and Care 47367 1Wyeth Donates 24100 000 to ASCO Cancer Foundation 28R 29 to Support Cancer Prevention and Care 47367 2Wyeth Donates 24100 000 to ASCO Cancer Foundation 28R 29 to Support Cancer Prevention and Care 47367 3
...NGTON, March 15, 2007 /PRNewswire/ -- Up to two mi...h up to 600,000,hospitalized. Its primary complica...0 lives annually -- more than breast cancer and,AI...Thrombosis (DVT) recently,sponsored an online surv...ers and physicians. The survey, which was conducte...
...ng-Plough Announces Presentation Of Phase II Trial...st At The 2007 Annual,Meeting Of The American Coll...ch 16, 2007 /PRNewswire-FirstCall/ --,Schering-Plo...e,Phase II trial of its novel oral thrombin recept...t the 2007 annual Scientific Sessions,of the of Ca...
Other Medicine Technology:DVT Awareness Survey Findings for Respondents in High-Risk Groups:,Obese Individuals 2Media Advisory: ACC Updated Schedule 2
Siemens Video: Smart Heart Scans for Athletes
The VPAP III ST-A combines the exclusive features of the popular VPAP III series with adjustable trigger and cycle thresholds and a full range of clinician and patient-friendly alarms in a new, strea
Siemens Webcast: Cardiovascular Computed Tomography (CVCT): A Cardiologists Perspective
GeroFlex reusable catheters for 24-hour esophageal pH monitoring. , ,The GeroFlex esophageal pH catheters are reusable up to five times. They are constructed of the same high quality materials as t
Medicine Products: